1. Home
  2. UFG vs BDTX Comparison

UFG vs BDTX Comparison

Compare UFG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFG
  • BDTX
  • Stock Information
  • Founded
  • UFG 2021
  • BDTX 2014
  • Country
  • UFG Singapore
  • BDTX United States
  • Employees
  • UFG N/A
  • BDTX N/A
  • Industry
  • UFG Oil Refining/Marketing
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UFG Energy
  • BDTX Health Care
  • Exchange
  • UFG Nasdaq
  • BDTX Nasdaq
  • Market Cap
  • UFG 136.4M
  • BDTX 126.2M
  • IPO Year
  • UFG 2025
  • BDTX 2020
  • Fundamental
  • Price
  • UFG $4.39
  • BDTX $2.16
  • Analyst Decision
  • UFG
  • BDTX Strong Buy
  • Analyst Count
  • UFG 0
  • BDTX 4
  • Target Price
  • UFG N/A
  • BDTX $15.50
  • AVG Volume (30 Days)
  • UFG 166.1K
  • BDTX 567.4K
  • Earning Date
  • UFG 01-01-0001
  • BDTX 03-11-2025
  • Dividend Yield
  • UFG N/A
  • BDTX N/A
  • EPS Growth
  • UFG N/A
  • BDTX N/A
  • EPS
  • UFG 0.02
  • BDTX N/A
  • Revenue
  • UFG $130,669,390.00
  • BDTX N/A
  • Revenue This Year
  • UFG N/A
  • BDTX N/A
  • Revenue Next Year
  • UFG N/A
  • BDTX N/A
  • P/E Ratio
  • UFG $225.13
  • BDTX N/A
  • Revenue Growth
  • UFG 129.69
  • BDTX N/A
  • 52 Week Low
  • UFG $3.82
  • BDTX $1.91
  • 52 Week High
  • UFG $5.10
  • BDTX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • UFG N/A
  • BDTX 42.32
  • Support Level
  • UFG N/A
  • BDTX $2.24
  • Resistance Level
  • UFG N/A
  • BDTX $2.47
  • Average True Range (ATR)
  • UFG 0.00
  • BDTX 0.16
  • MACD
  • UFG 0.00
  • BDTX -0.03
  • Stochastic Oscillator
  • UFG 0.00
  • BDTX 5.69

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: